Reaction

Toxoplasmosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,069 reports · 61 co-occurring drugs

As of the last recalculation, Toxoplasmosis appears in 1,069 FAERS reports alongside 61 co-occurring drug terms. The strongest observed disproportionality signal is VALGANCICLOVIR HYDROCHLORIDE POWDER, (PRR 101.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Valganciclovir Hydrochloride Powder,	60	101.4	101.9
Busulfan	73	96.9	97.3
Fludarabine Phosphate	124	69.3	69.5
Valganciclovir	60	65.6	65.8
Valganciclovir Hydrochloride	60	65.6	65.8
Ganciclovir Sodium	31	58.7	58.9
Ganciclovir	30	58.7	58.9
Anti-Thymocyte Globulin (Rabbit)	23	56.7	56.9
Polatuzumab Vedotin	27	55.2	55.4
Atovaquone	20	49.3	49.4
Mycophenolate Mofetil	260	48.9	49.0
Mycophenolate Mofetil Hydrochloride	260	48.8	48.9
Thiotepa	23	47.9	48.0
Tacrolimus Ointment 0.1%	231	45.8	45.9
Tacrolimus Extended-Release Capsules	231	45.7	45.8
Tacrolimus	259	42.2	42.2
Alemtuzumab	40	41.8	41.9
Sirolimus	24	35.5	35.5
Lopinavir And Ritonavir	22	32.2	32.3
Mesna Injection	13	31.0	31.0
Voriconazole Injection	33	30.5	30.5
Mesna	13	30.4	30.5
Daspone	15	30.4	30.4
Dapsone Gel, 5%	15	30.4	30.4
Basiliximab	17	28.6	28.6
Nevirapine	13	28.4	28.4
Dapsone	15	27.7	27.8
Cefuroxime	16	27.6	27.7
Ritonavir 100 Mg	20	26.5	26.6
Melphalan Hydrochloride	32	25.6	25.6
Melphalan	28	24.6	24.6
Lamivudine Oral	29	22.9	22.9
Voriconazole	34	22.5	22.5
Amphotericin B	14	22.0	22.1
Ritonavir	31	21.2	21.3
Micafungin Sodium	9	20.8	20.9
Lamivudine	32	20.8	20.8
Mycophenilic Acid	21	20.1	20.1
Darunavir	15	19.6	19.6
Fluconazole	66	19.5	19.5
Cyclophosphamide Injection, Solution	148	18.7	18.7
Cyclophosphamide	148	18.7	18.7
Cyclophosphamide For Injection	148	18.7	18.7
Abacavir Sulfate	9	18.1	18.1
Cyclosporine	87	16.5	16.5
Iron Sucrose	8	16.5	16.5
Zidovudine	11	16.2	16.2
Mycophenolic Acid	25	15.5	15.6
Atazanavir	10	13.7	13.7
Raltegravir	11	13.1	13.1
Acyclovir	72	13.1	13.1
Cytarabine	35	11.7	11.7
Efavirenz	6	10.5	10.5
Pyrazinamide	5	10.4	10.4
Doxorubicin	43	9.7	9.8
Daptomycin	4	8.5	8.5
Obinutuzumab	7	8.3	8.3
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	6	6.5	6.5
Emtricitabine And Tenofovir Disoproxil Fumarate	14	6.0	6.0
Eltrombopag Olamine	7	5.9	5.9
Remdesivir	4	5.9	5.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.